AYTU BIOPHARMA, INC Inventory Valuation Reserves
AYTU BIOPHARMA, INC (AYTU) had Inventory Valuation Reserves of $2.50 million as of 2021-06-30, per its 10-K filed 2021-09-28.
Discontinued › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryValuationReserves · last filed 2021-09-28
- 2021-06-30: Inventory Valuation Reserves $2.50M.
- 2020-06-30: Inventory Valuation Reserves $1.30M.
- 2019-06-30: Inventory Valuation Reserves $0.00.
- 2019-03-31: Inventory Valuation Reserves $10.00K.
| Period end | Inventory Valuation Reserves |
|---|---|
| 2021-06-30 | $2.50M 10-K · filed 2021-09-28 |
| 2020-06-30 | $1.30M 10-K · filed 2021-09-28 |
| 2019-06-30 | $0.00 10-K · filed 2020-10-06 |
| 2019-03-31 | $10.00K 10-Q · filed 2019-05-14 |
| 2018-06-30 | $0.00 10-Q · filed 2019-05-14 |
| 2017-06-30 | $310.00K 10-K · filed 2018-09-06 |
| 2016-06-30 | $199.00K 10-K · filed 2017-08-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |